Hypermethylation of the MTHFR promoter in blood samples has been linked to other relevant clinical conditions, such as women who have had recurrent miscarriages (Mishra et al., 2019) and mothers of Down syndrome patients (Coppedè et al., 2016). This evidence concerns the gene MTHFR and Down syndrome.